Domainex and Imperial College London Partner to Discover New Therapies to Treat Myocardial Infarction


Domainex Ltd. and Imperial College London today announce a new partnership focused on the discovery of novel therapies to treat myocardial infarction, also known as a heart attack. This follows the success of Imperial in securing £3M in funding from the Wellcome Trust Seeding Drug Discovery programme to build upon the pioneering research of Professor …


Continue reading

Breathe a sigh of relief


PR-PR15-027_Winners-v0.8(s)

Young innovators gather to help improve the lives of patients with respiratory disease An immersive gaming experience to give children a taste of life with respiratory problems and discourage them from taking up smoking – that was the winning innovation from the UK’s recent BREATHE Respiratory Hackathon. The event at Imperial College London brought together …


Continue reading

Red Dot Design Award for KiCoPen


PR-PR15-026_Mainimag v0.7

International acclaim for smart insulin pen concept from Cambridge Consultants Product design and development firm Cambridge Consultants has won a prestigious Red Dot Design Award for its KiCoPen smart insulin pen concept. The company was up against nearly 5,000 entries from 63 countries in the design concept category of the awards – one of the …


Continue reading

Lucideon to Host Reception to Celebrate Opening of New Healthcare Technologies Office in Cambridge Science Park on 18th November


Lucideon, the international materials technology company, will be celebrating the opening of its new Healthcare Technologies office in Cambridge Science Park with a reception on 18 November. The event, which will run from 5 – 7 pm at the Trinity Centre, will give local companies a chance to meet the Healthcare Science team and find …


Continue reading

Auspherix and Domainex Expand Collaboration


Domainex and Auspherix have announced an expansion of their collaboration to develop new drugs to tackle the growing threat of resistance to antibiotics. The programme has been extended through to 2017. Since initiating the project in 2014, significant progress has been made towards the invention of new compounds with activity against both gram-positive and gram-negative bacteria. The collaboration …


Continue reading

Combining Cambridge Technologies for the future of healthcare


Cambridge Science Park tenants are invited to attend the forthcoming Combining Cambridge Technologies for the Future of healthcare conference which takes place on 1st October at the Cambridge City Hotel, Downing Street Cambridge. Delegate places cost £65 for the day conference. The objective for the day is to initiate a debate about how using and combining healthcare technologies …


Continue reading

The future of neuromodulation


Neuromodulation

Why the industry needs to shift to high-volume, low-cost, disease-management solutions Miniaturised implants providing targeted nerve stimulation – perhaps even put in place via a simple injection in the doctor’s surgery. That’s the vision for the future of neuromodulation painted by product design and development firm Cambridge Consultants. The company says demand for mass-market therapies …


Continue reading